Search   
MSDS  : 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-(2-phenoxy- acetamido)-, monopotassium salt
CAS  : 132-98-9
SYNONYMS  : * Apsin VK * Beromycin * Beromycin (penicillin) * Betapen-VK * Calciopen K * Cliacil * Compocillin-VK * Distakaps V-K * Distaquaine V-K * Dowpen V-K * Fenoxypen * Isocillin * Megacillin oral * Oracil-VK * Orapen * Ospeneff * Pedipen * Penagen * Pencompren * Penicillin potassium phenoxymethyl * Penicillin V potassium * Penicillin V potassium salt * Pen-Vee-K * Pen-Vee-K powder * Pen-V-K powder * Penvikal * D-alpha-Phenoxymethylpenicillinate K salt * Phenoxymethylpenicillin potassium * Potassium penicillin V * Potassium penicillin V salt * Potassium phenoxymethylpenicillin * Primcillin * Qidpen VK * Robicillin VK * Rocillin-VK * Roscopenin * SK-Penicillin VK * Stabillin VK syrup 125 * Stabillin VK syrup 62.5 * Sumapen VK * V-Cillin K * Veetids * Vepen
*** CHEMICAL IDENTIFICATION ***

RTECS NUMBER : XH9275000
CHEMICAL NAME : 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid,
3,3-dimethyl-7-oxo-6-(2-phenoxy- acetamido)-,
monopotassium salt
CAS REGISTRY NUMBER : 132-98-9
LAST UPDATED : 199707
DATA ITEMS CITED : 17
MOLECULAR FORMULA : C16-H17-N2-O5-S.K
MOLECULAR WEIGHT : 388.51
WISWESSER LINE NOTATION : T45 ANV ESTJ CMV1OR& F1 F1 GVQ &-KA-
COMPOUND DESCRIPTOR : Tumorigen
Drug
Mutagen
SYNONYMS/TRADE NAMES :
* Apsin VK
* Beromycin
* Beromycin (penicillin)
* Betapen-VK
* Calciopen K
* Cliacil
* Compocillin-VK
* Distakaps V-K
* Distaquaine V-K
* Dowpen V-K
* Fenoxypen
* Isocillin
* Megacillin oral
* Oracil-VK
* Orapen
* Ospeneff
* Pedipen
* Penagen
* Pencompren
* Penicillin potassium phenoxymethyl
* Penicillin V potassium
* Penicillin V potassium salt
* Pen-Vee-K
* Pen-Vee-K powder
* Pen-V-K powder
* Penvikal
* D-alpha-Phenoxymethylpenicillinate K salt
* Phenoxymethylpenicillin potassium
* Potassium penicillin V
* Potassium penicillin V salt
* Potassium phenoxymethylpenicillin
* Primcillin
* Qidpen VK
* Robicillin VK
* Rocillin-VK
* Roscopenin
* SK-Penicillin VK
* Stabillin VK syrup 125
* Stabillin VK syrup 62.5
* Sumapen VK
* V-Cillin K
* Veetids
* Vepen

*** HEALTH HAZARD DATA ***

** ACUTE TOXICITY DATA **

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : >1040 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E.
First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year:
18,185,1971

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 1750 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag,
Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951-
Volume(issue)/page/year: 12,751,1962

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intramuscular
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 1124 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
PJPPAA Polish Journal of Pharmacology and Pharmacy. (ARS Polona, POB 1001,
00-068 Warsaw 1, Poland) V.25- 1973- Volume(issue)/page/year: 29,39,1977

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : >4 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo,
Japan) Volume(issue)/page/year: 6,661,1982

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 1351 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo,
Japan) Volume(issue)/page/year: 6,661,1982

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : >4 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo,
Japan) Volume(issue)/page/year: 6,661,1982

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 1 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag,
Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951-
Volume(issue)/page/year: 12,751,1962

** OTHER MULTIPLE DOSE TOXICITY DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 195 gm/kg/13W-I
TOXIC EFFECTS :
Gastrointestinal - other changes
Nutritional and Gross Metabolic - weight loss or decreased weight gain
REFERENCE :
TXCYAC Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85,
Limerick, Ireland) V.1- 1973- Volume(issue)/page/year: 56,123,1989

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 16250 mg/kg/13W-I
TOXIC EFFECTS :
Gastrointestinal - other changes
REFERENCE :
TXCYAC Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85,
Limerick, Ireland) V.1- 1973- Volume(issue)/page/year: 56,123,1989

** MUTATION DATA **

TYPE OF TEST : Cytogenetic analysis
TEST SYSTEM : Human Lymphocyte
DOSE/DURATION : 3 gm/L
REFERENCE :
MUTAEX Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road,
Eynsham, Oxford OX8 1JJ, UK) V.1- 1986- Volume(issue)/page/year: 4,439,1989

TYPE OF TEST : Mutation in microorganisms
TEST SYSTEM : Rodent - mouse Lymphocyte
DOSE/DURATION : 250 mg/L
REFERENCE :
EMMUEG Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E.
11th St., New York, NY 10003) V.10- 1987- Volume(issue)/page/year:
12(Suppl 13),103,1988

TYPE OF TEST : Cytogenetic analysis
TEST SYSTEM : Rodent - hamster Ovary
DOSE/DURATION : 9 gm/L
REFERENCE :
NTPTR* National Toxicology Program Technical Report Series. (Research
Triangle Park, NC 27709) No.206- Volume(issue)/page/year: NTP-TR-336,1988

TYPE OF TEST : Sister chromatid exchange
TEST SYSTEM : Rodent - hamster Ovary
DOSE/DURATION : 500 mg/L
REFERENCE :
NTPTR* National Toxicology Program Technical Report Series. (Research
Triangle Park, NC 27709) No.206- Volume(issue)/page/year: NTP-TR-336,1988

*** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA ***

NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA :
NOHS - National Occupational Hazard Survey (1974)
NOHS Hazard Code - 82270
No. of Facilities: 1844 (estimated)
No. of Industries: 2
No. of Occupations: 3
No. of Employees: 3026 (estimated)

NOES - National Occupational Exposure Survey (1983)
NOES Hazard Code - 82270
No. of Facilities: 301 (estimated)
No. of Industries: 2
No. of Occupations: 11
No. of Employees: 6483 (estimated)
No. of Female Employees: 3052 (estimated)

*** STATUS IN U.S. ***

EPA TSCA Section 8(b) CHEMICAL INVENTORY

NTP Carcinogenesis Studies (gavage);no evidence:mouse,rat
NTPTR* National Toxicology Program Technical Report Series. (Research
Triangle Park, NC 27709) No.206- Volume(issue)/page/year: NTP-TR-336,88


*** END OF RECORD ***
Search More   
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
NAMECAS
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid,3,3-dimethyl-6-((2,2-dimethyl-1-oxopropyl)amino)-7-oxo-, monosodium salt 20520-33-6
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid,3,3-dimethyl-6-(((((2,3-dioxo-4-propyl-1-piperazinyl)carbonyl)amino)phenylacetyl)amino)-7-oxo-, (2S-(2-alpha,5-alpha,6-beta(S*)))- 65125-88-4
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid,3,3-dimethyl-6-(((((4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl)amino)phenylacetyl)amino)-7-oxo-, (2S-(2-alpha,5-alpha,6-beta(S*)))- 61477-96-1
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid,3,3-dimethyl-6-(((3-fluoro-4-methoxyphenoxy)acetyl)amino)-7-oxo-, monopotassiumsalt, (2S-(2-alpha,5-alpha,6-beta))- 15440-46-7
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid,3,3-dimethyl-6-hexanamido-7-oxo- 4493-18-9
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid,3,3-dimethyl-6-(3-hexenamido)-7-oxo- 118-53-6
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid,3,3-dimethyl-6-((((((2-hydroxybenzoyl)hydrazono)acetyl)amino)phenylacetyl)amino)-7-oxo-,(2S-(2-alpha,5-alpha,6-beta(S*)))- 143667-43-0
Thallium selenide 12039-52-0
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid,3,3-dimethyl-6-(2-(p-hydroxyphenyl) acetamido)-7-oxo- 525-91-7
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid,3,3-dimethyl-6-((((((4-hydroxy-3-(2-propenyl)benzoyl)hydrazono)acetyl)amino)phenylacetyl)amino)-7-oxo-, (2S-(2-alpha,5- alpha,6-beta(S*)))- 143667-51-0
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid,3,3-dimethyl-6-((((((4-(methylamino)benzoyl)hydrazono)acetyl)amino)phenylacetyl)amino)-7-oxo-, (2S-(2-alpha,5-alpha,6-beta (S*)))- 143667-45-2
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid,3,3-dimethyl-6-((((((3-methylbenzoyl)hydrazono)acetyl)amino)phenylacetyl)amino)-7-oxo-,(2S-(2-alpha,5-alpha,6-beta(S*)))- 143667-42-9
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid,3,3-dimethyl-6-(((((4-methyl-2,3-dioxo-1-piperazinyl)carbonyl)amino)phenylacetyl)amino)-7-oxo-, (2S-(2-alpha,5-alpha,6-beta(S*)))- 59723-60-3
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid,3,3-dimethyl-6-(((4-methylphenoxy)acetyl)amino)-7-oxo-, monopotassium salt,(2S-(2-alpha,5-alpha,6-beta))- 15545-38-7
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid,3,3-dimethyl-6-(5-methyl-3-phenyl-4-isoxazolecarboxamide)-7-oxo- 66-79-5
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid,3,3-dimethyl-6-(5-methyl-3-phenyl-4-isoxazolecarboxamido)-7-oxo-, monosodium salt 1173-88-2
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid,3,3-dimethyl-6-(((((3-(methylsulfonyl)-2-oxo-1-imidazolidinyl)carbonyl)amino)phenylacetyl)amino)-7-oxo-, sodium salt,(2S-(2-alpha,5-alpha,6-beta)(S*))- 42057-22-7
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid,3,3-dimethyl-6-octanamido-7-oxo- 525-97-3
Thallium(I) selenite 525-97-3
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid,3,3-dimethyl-6-(((((4-octyl-2,3-dioxo-1-piperazinyl)carboxyl)amino)phenylacetyl)amino)-7-oxo-, (2S-(2-alpha,5-alpha,6-beta(S*)))- 59703-98-9
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid,3,3-dimethyl-7-oxo-6-(butylthio acetamido)- 6192-29-6
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid,3,3-dimethyl-7-oxo-, 4,4-dioxide, sodium salt,(2S-cis)- 69388-84-7
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid,3,3-dimethyl-7-oxo-6-(((((2-oxo-1-imidazolidinyl)carbonyl)amino)phenylacetyl)amino)-,monosodium salt, (2S-(2-alpha,5-alpha,6-beta(S*)))- 37091-65-9
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid,3,3-dimethyl-7-oxo-6-(2- phenoxyacetamido)-, compd.with N,N'-dibenzylethylenediamine (2:1) 5928-84-7
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid,3,3-dimethyl-7-oxo-6- (2-phenoxyacetamido)-, compd.with4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-N-((4-(2-hydroxyethyl)-1-piperazinyl)methyl)-6- methyl-1,11-dioxo-2-naphthacenecarboxamide (1:1) 4599-60-4
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid,3,3-dimethyl-7-oxo-6-(2-phenoxy- acetamido)-,monopotassium salt 132-98-9
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid,3,3-dimethyl-7-oxo-6-(2-phenoxy acetamido)-,monosodium salt 1098-87-9
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid,3,3-dimethyl-7-oxo-6-((((((4-phenoxybenzoyl)hydrazono)acetyl)amino)phenylacetyl)amino)-, (2S-(2-alpha,5-alpha,6-beta(S*)))- 143729-85-5
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid,3,3-dimethyl-7-oxo-6-(2-phenoxy butyramido)-, compd.with dibenzylamine 102367-60-2
Thallium sulfate 10031-59-1
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid,3,3-dimethyl-7-oxo-6- (2-phenoxybutyramido)-,monopotassium salt 1245-44-9
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid,3,3-dimethyl-7-oxo-6- (2-phenoxybutyramido)-, sodiumsalt 31090-17-2
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid,3,3-dimethyl-7-oxo-6-(2-phenoxy butyramido)-,monosodium salt, L- 102367-61-3
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid,3,3-dimethyl-7-oxo-6-((phenoxyphenyl acetyl)amino)-,monopotassium salt 1177-30-6
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid,3,3-dimethyl-7-oxo-6-(2- phenoxypropionamido)- 147-55-7
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid,3,3-dimethyl-7-oxo-6-(2- phenoxypropionamido)-,monopotassium salt 132-93-4
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid,3,3-dimethyl-7-oxo-6- (2-phenylacetamido)- 61-33-6
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid,3,3-dimethyl-7-oxo- 6-(2-phenylacetamido)-, ammoniumsalt 61-33-6
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid,3,3-dimethyl-7-oxo-6-(2-phenyl acetamido)-, compd.with dibenzylamine 7179-52-4
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid,3,3-dimethyl-7-oxo-6- (2-phenylacetamido)-, compd.with N,N'-dibenzylethylenediamine (2:1) 1538-09-6
Thallium(I) sulfate (21) 7446-18-6
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid,3,3-dimethyl-7-oxo-6-(2- phenylacetamido)-, compd.with 2-(diethylamino)ethyl p-aminobenzoate (1:1) 54-35-3
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxilic acid,3,3-dimethyl-7-oxo-6-(2-phenyl acetamido)-, compd.with 2-(diethylamino)ethyl p-aminobenzoate (1:1),monohydrate 6130-64-9
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid,3,3-dimethyl-7-oxo-6- (2-phenylacetamido)-,2-(diethylamino)ethyl ester 3689-73-4
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid,3,3-dimethyl-7-oxo-6- (2-phenylacetamido)-, compdwith ephedrine (1:1) 7177-45-9
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid,3,3-dimethyl-7-oxo-6- (2-phenylacetamido)-, compd.with alpha,alpha'-(ethylenediimino)di-o-cresol 3841-12-1
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid,3,3-dimethyl-7-oxo-6- (2-phenylacetamido)-,monopotassium salt 113-98-4
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid,3,3-dimethyl-7-oxo-6-(2-phenyl acetamido)-,monosodium salt 69-57-8
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid,3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)-2S-(2-alpha,5-alpha,6-beta))-, compd. with(1R-(1-alpha(1R*,4aS*,10aR*),4a-beta,10a-alpha))-N,N'-bis((1,2,3,4,4a,9,10,10a-octahydro-1,4a-dimethyl-7-(1-methyle thyl)-1-phenanthrenyl)methyl)-1,2-ethanediamine (2:1) 3344-16-9
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid,3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)-(2S-(2-alpha,5-alpha,6-beta))-,compd. with 1-p-chlorobenzyl-2-pyrrolidyl-methylbenzimidazol 3344-16-9

Free MSDS Search ( Providing 250,000+ Material Properties )
Chemcas.com| Ads link:todaystock.net